ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,529.42
      1.71%
      US Tech 100
      18,778.40
      2.61%
      Dow Jones
      40,926.68
      0.45%
      Brent Oil
      80.115
      1.97%
      Bitcoin
      66,315.50
      0.22%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NYSE

      6. John Hancock Preferred Income Fund II (HPF) Quote

      John Hancock Preferred Income Fund II

      John Hancock Preferred Income Fund II (HPF)

      Harvest Energy Leaders Plus Income ETF
      17.00
      0.09
      ( 0.53% )
      Updated: 10:17:18
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      17.00
      Bid
      -
      Ask
      -
      Volume
      15,377
      16.90 Day's Range 17.00
      12.9885 52 Week Range 17.78
      Market Cap
      365.691M
      Previous Close
      16.91
      Open
      17.00
      Last Trade
      28
      @
      17
      Last Trade Time
      10:17:22
      Financial Volume
      $ 261,080
      VWAP
      16.9786
      Average Volume (3m)
      38,714
      Shares Outstanding
      21,511,260
      Dividend Yield
      8.72%
      PE Ratio
      -14.65
      Earnings Per Share (EPS)
      -1.16
      Revenue
      38.1M
      Net Profit
      -24.96M

      About John Hancock Preferred Income Fund II

      John Hancock Preferred Income Fund II is a United States based closed-end, diversified management investment company. Its primary objective is to provide a high level of current income consistent with preservation of capital. Under normal market conditions, the fund invests at least 80% of its asset... John Hancock Preferred Income Fund II is a United States based closed-end, diversified management investment company. Its primary objective is to provide a high level of current income consistent with preservation of capital. Under normal market conditions, the fund invests at least 80% of its assets (net assets plus borrowings for investment purposes) in preferred stocks and other preferred securities, including convertible preferred securities. This is a non-fundamental policy and may be changed by the Board of Trustees of the fund provided that shareholders are provided with at least 60 days prior written notice of any change as required by the rules under the 1940 Act. The fund intends to invest primarily in fully taxable preferred securities. The funds portfolio of preferred securities may include both fixed rate and adjustable rate securities. Show more

      Sector
      Unit Inv Tr, Closed-end Mgmt
      Industry
      Unit Inv Tr, Closed-end Mgmt
      Website
      www.jhfunds.com
      Headquarters
      Boston, Massachusetts, USA
      Founded
      1970
      John Hancock Preferred Income Fund II is listed in the Unit Inv Tr, Closed-end Mgmt sector of the New York Stock Exchange with ticker HPF. The last closing price for John Hancock Preferred I... was $16.91. Over the last year, John Hancock Preferred I... shares have traded in a share price range of $ 12.9885 to $ 17.78.

      John Hancock Preferred I... currently has 21,511,260 shares outstanding. The market capitalization of John Hancock Preferred I... is $363.76 million. John Hancock Preferred I... has a price to earnings ratio (PE ratio) of -14.65.

      HPF Latest News

      More News

      Xeris Biopharma to Report Second Quarter 2024 Financial Results on August 8, 2024

      Conference call and webcast at 8:30am ET Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patients’ lives by developing and...

      July 25 2024
      Business Wire

      Form 8-K - Current report

      July 08 2024
      Edgar (US Regulatory)

      Xeris Biopharma Announces CEO Succession Plan

      John Shannon, President and Chief Operating Officer, to succeed Paul Edick as new CEO and Board Director Transition timing aligns with the solid financial position of the Company, including...

      July 08 2024
      Business Wire

      Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

      Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a...

      July 03 2024
      Business Wire

      Form 4 - Statement of changes in beneficial ownership of securities

      June 05 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      June 05 2024
      Edgar (US Regulatory)

      Xeris Presents New Post Hoc Analysis on Effects of Levoketoconazole (Recorlev®) in Cushing’s Syndrome Patients at ENDO 2024

      In patients with Cushing’s syndrome maintained on Recorlev, a lower baseline mUFC was associated with higher cortisol normalization rate. Lower mUFC at baseline was also associated with lower...

      June 03 2024
      Business Wire

      Xeris Biopharma Announces Positive Topline Phase 2 Clinical Data of Its Investigational XeriSol™-Formulated Once-Weekly Subcutaneous (SC) Levothyroxine (XP-8121)

      XeriSol™ formulation enabled predictable bioavailability and sustained levels of levothyroxine in a once-weekly subcutaneous presentation Once-weekly SC levothyroxine (XP-8121) participants...

      May 30 2024
      Business Wire

      Xeris to Participate in the Jefferies Global Healthcare Conference

      Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patients’ lives by developing and commercializing innovative products across a...

      May 30 2024
      Business Wire

      Form 8-K - Current report

      May 09 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.362.1634615384616.641716.54123716.64605061CS
      4-0.08-0.46838407494117.0817.2216.54554916.87839121CS
      12-0.09-0.52662375658317.0917.7816.453871417.02081737CS
      260.684.1666666666716.3217.7815.394436816.62202564CS
      521.5810.246433203615.4217.7812.98854249515.78874919CS
      156-5.15-23.250564334122.1522.9312.98854253117.2033379CS
      260-6.6-27.966101694923.623.8295007518.12905329CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      BEDUBright Scholar Education Holdings Limited
      $ 1.99
      (20.61%)
      		1.42k
      CCMConcord Medical Services Holdings Ltd
      $ 7.2898
      (17.58%)
      		73.52k
      FVRRFiverr International Ltd
      $ 24.715
      (12.91%)
      		622.03k
      VSTVistra Corp
      $ 77.705
      (12.62%)
      		5.31M
      PSNParsons Corporation
      $ 86.86
      (12.54%)
      		900.84k
      FNAParagon 28 Inc
      $ 7.21
      (-20.16%)
      		347.69k
      CHCTCommmunity Healthcare Trust
      $ 22.43
      (-18.47%)
      		334.07k
      LEVLion Electric Company
      $ 0.70045
      (-18.15%)
      		439.83k
      LMNDLemonade Inc
      $ 18.77
      (-17.06%)
      		2.09M
      ANROAlto Neuroscience Inc
      $ 11.5475
      (-15.90%)
      		144.06k
      LUMNLumen Technologies Inc
      $ 2.545
      (-4.68%)
      		20.51M
      FFord Motor Company
      $ 10.845
      (0.05%)
      		14.48M
      ABEVAmbev SA
      $ 2.06
      (-1.44%)
      		11.82M
      PINSPinterest Inc
      $ 33.04
      (-11.54%)
      		11.05M
      NIONIO Inc
      $ 4.52
      (2.26%)
      		9.46M

      Discussion

      View Full Feed
      palaypu0406 palaypu0406 3 minutes ago
      The price cut is not necessarily the target cut - In fact with the price change, target increased multi-fold --
      From 6 bricks inventory, we are now planning to hole up 1 Ton (80 Bricks)...
      we are seeing demand absorption multi-fold.... From price at 27 to price around $9, absorption
      ITUP
      Lurker3 Lurker3 3 minutes ago
      Which news? A new patent? An other conference? A new director? A new benzinga interview? New office supplies?

      Those types of news r more likely to be announced then any deal to date.
      LWLG
      ChannelTrader ChannelTrader 3 minutes ago
      https://x.com/Channel_Trader/status/1818656641224454407
      Hercules1 Hercules1 3 minutes ago
      opportunity fleeting fast.

      this will be breaking .004 fairly quickly.

      i cant see it closing under .004 today.

      HIRU
      stock1ace1 stock1ace1 3 minutes ago
      Sxtc $1.16
      FeMike FeMike 3 minutes ago
      If you don't know what those 'events' are, then should you be an investor ?

      Wild that you can't seem to list what these 'events' are either.
      NWBO
      GARYM1 GARYM1 3 minutes ago
      I won't make that decision until 2nd half of year is over.
      The ramp up in 2nd half could still happen
      SEV
      GLENO34 GLENO34 3 minutes ago
      5531 is the 15 min 320MA which "could" act as REZ???


      https://schrts.co/pWYAVpDa
      WhAtEvA1 WhAtEvA1 3 minutes ago
      Just another all around drivel of nonsensical garbage . The overall point this dude is revolves round the effort to solicit and incite venom against the FDA. For whatever reasons only the Almighty will know. Perhaps looking for data to take to his connects and say you see, they need your approval bu
      IBIO
      manibiotech manibiotech 3 minutes ago
      Well said
      NWBO
      MartinLutherKing MartinLutherKing 3 minutes ago
      It’s under the pressure cooker
      RNAZ
      Steady_T Steady_T 4 minutes ago
      Gosh, Who knew that things could change since the P2a trial?

      Sheesh.
      AVXL
      train21 train21 4 minutes ago
      $PSRU I be buying up cheap shares every week eventually its going to fly ???///// $$$$$$$$$$$$$$$$$$$
      PSRU
      ducci1 ducci1 4 minutes ago
      Vix bottomed out at 16.23 last 3 days ?
      SPY
      Nemesis18 Nemesis18 4 minutes ago
      If you hadn't worked it out already, 'stealth mode', related to the attempted resurrection of DIRECT in the UK 🇬🇧
      NWBO
      ANTI-BAGHOLDER ANTI-BAGHOLDER 4 minutes ago
      MONI news out.

      https://x.com/moonequity/status/1818655003466518632?s=46
      MONI
      JJZander JJZander 4 minutes ago
      Exactly
      HIRU
      WillForeall WillForeall 4 minutes ago
      Hahahaha I’m watching like a hawk yummm
      HIRU
      haha11 haha11 4 minutes ago
      $TQQQ.......60.+...Daily.....daily trend HH....With GAP under....7/31/24

      60...
      https://schrts.co/kImcIiRd
      daily.
      https://schrts.co/yKKwMJAY
      TQQQ
      Moonboy1 Moonboy1 4 minutes ago
      This dude s holding up better than I thought it would. I may buy a few shares back to hold for a few days to see what this does.
      FFIE
      Stockfire409 Stockfire409 4 minutes ago
      Rarely if ever do we see 8-K's of PR's in the OTC swamp. Strong messaging here.
      HIRU
      europa7 europa7 4 minutes ago
      are you ready...player one...?

      a little something for you gamer and metaverse fans out there...another XRP use case in the works...cheers...

      OPEN - Official Teaser Trailer (Ready Player One Battle Royale)
      https://www.youtube.com/watch?v=_P2s2Uz89pM

      XRPUSD
      1plus1 1plus1 4 minutes ago
      who's trying haaaaaaard ???
      HIRU
      StockItOut StockItOut 4 minutes ago
      All this Xeriant incapability to make a Nexboard. The reason Movychem was 'fired'. And per that Xeriant/Movychem JV, Movychem was not the responsible party to manufacture Nexboards. Those Nexboards that were PRed by Xeriant on June 8th, 2022, as "successfully developed." And Xeriant/Duffy/Defuedis
      TMF
      GREGG THE GREEK GREGG THE GREEK 4 minutes ago
      Took a small starter here this morning.

      Thanks !!!


      STI
      STI

      Your Recent History

      NYSE
      HPF
      John Hancock Preferred I...
      Delayed Upgrade Clock